To the Editor: Our positive experience with insulin pump therapy (IPT) in children without private health insurance contrasts with that of Thong and colleagues,1 who found that IPT did not significantly reduce glycated haemoglobin (HbA1c) levels in uninsured adults.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
Comments from Professor Kevin Grumbach and Professor Tom Bodenheimer are gratefully acknowledged.
Medtronic Australasia provided a grant to research and publish the results of our rural insulin pump program. Medtronic had no input into the content of this letter. I attended Australian Paediatric Society insulin pump workshops in 2008 and 2009 that were sponsored by Medtronic, Animas, Cosmo, Novo Nordisk and Lilly. I have received two Novo Nordisk regional diabetes grants for rural diabetes research.